Streetbeat News

Price Targets

BSX

RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Boston Scientific (NYSE:BSX) and maintained a price target of $67.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:15 pm

BA

Boeing's stock (BA) trades lower following a downgrade by Wells Fargo from Overweight to Equal-Weight and a reduction in the price target from $280 to $225.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:15 pm

CNQ

RBC Capital analyst Greg Pardy has reiterated an Outperform rating on Canadian Natural Resources (TSX:CNQ) and maintained a price target of C$94.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:14 pm

QURE

RBC Capital analyst Luca Issi has reiterated an Outperform rating on uniQure (NASDAQ:QURE) and maintained a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:12 pm

UNH

RBC Capital analyst Ben Hendrix has reiterated an Outperform rating on UnitedHealth Group (NYSE:UNH) and maintained a price target of $596.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:10 pm

GDRX

RBC Capital analyst Sean Dodge has maintained a 'Sector Perform' rating on GoodRx Holdings (NASDAQ:GDRX) and increased the price target from $5 to $7.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:07 pm

VEEV

RBC Capital analyst Rishi Jaluria has maintained an Outperform rating on Veeva Systems (VEEV) and increased the price target from $225 to $250.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:06 pm

GIII

G-III Apparel Group (NASDAQ:GIII) received mixed analyst ratings with 1 somewhat bullish, 5 indifferent, and 1 somewhat bearish over the last quarter. The average 12-month price target is $28.43, up 15.57% from the previous $24.60. Analysts from Wells Fargo, UBS, Barclays, Telsey Advisory Group, and Keybanc have adjusted their price targets, reflecting a positive outlook on the company's performance. G-III Apparel Group, a textile company with brands like DKNY and Calvin Klein, has shown strong profitability with a net margin of 11.96% and ROE of 8.85%, but faced a revenue decline of -1.04% over 3 months.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 2:00 pm

DDOG

Datadog (NASDAQ:DDOG) has received mixed analyst ratings over the past three months, with 12 analysts offering diverse perspectives. The average 12-month price target for DDOG is now $117.5, up from $102.89, with a high estimate of $140 and a low of $84. Recent actions by analysts include both raised and lowered price targets and ratings, reflecting adjustments to market conditions and company performance. Datadog's financials show a revenue growth rate of 25.43% as of September 30, 2023, but it has below-average net margin, ROE, and ROA, indicating potential profitability and efficiency challenges. The company's debt-to-equity ratio is below the industry average, suggesting a healthier balance between debt and equity.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 2:00 pm

ABBV

CCI

MPC

SYK

On CNBC's 'Halftime Report Final Trades,' analysts recommended Crown Castle Inc. (CCI), Marathon Petroleum Corporation (MPC), Stryker Corporation (SYK), and AbbVie Inc. (ABBV). CCI announced a review of its Fiber business and new board members. MPC appointed new executives. SYK received a higher price target from RBC Capital. ABBV announced a collaboration with Umoja Biopharma. CCI's stock was flat, while MPC, SYK, and ABBV saw gains in their last trading session.

Portfolio Pulse from Avi Kapoor

January 16, 2024 | 1:51 pm